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EBV Persistence in Memory B Cells In Vivo
and Rowe, 1992), which is dispensable for immortaliza-Gregory J. Babcock,* Lisa L. Decker,*
tion but may play a critical role in the maintenance ofMark Volk,² and David A. Thorley-Lawson*³
latency in resting cells.*Department of Pathology
The presence of latent EBV in resting B cells createsTufts University School of Medicine
a paradoxÐhow does EBV, which drives infected cellsBoston, Massachusetts 02111
to proliferate in vitro, manage to persist in a resting cell²Department of Otolaryngology
in vivo? There are two possibilities. Either the virus isNew England Medical Center Hospital
able to establish latency directly in resting B cells inBoston, Massachusetts 02111
vivo, or the newly infected cells become activated and
proliferate but are able to exit from the cell cycle. Several
arguments favor the latter explanation. First, the viralSummary
DNA in the resting B cells is a covalently closed circular
episome (Decker et al., 1996) that forms in vitro whenEpstein-Barr virus establishes latency in vitro by acti-
an infected cell becomes activated and enters the cellvating human B cells to become proliferating blasts,
cycle (Hurley and Thorley-Lawson, 1988). Therefore, thebut in vivo it is benign. In the peripheral blood, the
resting cells must have been proliferating at some pointvirus resides latently in resting B cells that we now
in time. Second, the transcriptional program of EBV isshow are restricted to the sIgD2 memory subset. How-
complex and appears to be specifically designed toever, in tonsils the virus shows no such restriction.
efficiently activate newly infected B cells and drive themWe propose that EBV indiscriminately infects B cells
into the cell cycle. It is unclear how EBV could enter ain mucosal lymphoid tissue and that these cells differ-
resting B cell and quiescently establish latency withoutentiate to become resting memory B cells that then
initiating this program,but if it could the activation mech-enter the circulation. Activation to the blastoid stage
anism would be unnecessary. In fact, the ability to acti-of latency is an essential intermediate step in this pro-
vate B cells has been retained even though it posescess. Thus, EBV may persist by exploiting the mecha-
a threat, predisposition to neoplasia, to the very hostnisms that produce and maintain long-term B cell
organism that the virus depends on for long-term persis-memory.
tence and survival. Therefore, EBV must have evolved a
mechanism for B cell activation because it is an essential
Introduction
step in the establishment of long-term persistence. In
this case, acute EBV infection in vivo would initially result
Infection by the human herpesvirus Epstein-Barr virus in the indiscriminate infection, activation, and prolifera-
(EBV) is a predisposing factor for several human neopla- tion of B cells. Subsequently, these cells would enter
sias (reviewed in Rickinson and Kieff, 1996). The 175 kb into a quiescent state, associated with down-regulation
genome carries all of the information necessary to infect of the latent genes. An attractive aspect of this proposal
any resting, mature B cell in vitro and activate it to is that it precisely mimics the known behavior of B cells
become a proliferating B lymphoblast. To achieve this, during a response to an antigen (reviewed in MacLen-
the virus expresses five essential latent genes (reviewed nan, 1994; Liu et al., 1996).
in Kieff, 1996). A complex and tightly regulated transcrip- When a circulating naive (surface IgD1) or memory
tional process precisely controls the timing and levels (sIg1 but sIgD2) B cell percolates through lymphoid tis-
of expression of these proteins during the establishment sue, it becomes activated by specific antigen in combi-
and maintenance of the proliferating, latently infected nation with T cell help, in the form of CD40 cross-linking
state. Thus, the virus has evolved a sophisticated mech- and lymphokines. The B cells become proliferating
anism to guarantee that whenever it comes into contact blasts phenotypically indistinguishable from Bcells acti-
with a target B cell it will efficiently establish latency vated by EBV infection. These activated B cell blasts
and drive the cell to proliferate. then loose their sIgD, express a switched isotype (IgM,
Nevertheless, EBV is usually a benign, persistent vi- G, E, or A) on their surface, and terminally differentiate
rus. No viral replication is detectable in the peripheral into antibody-secreting plasma cells until antigen be-
blood (Decker et al., 1996) of healthy individuals (.95% comes limiting. In this case, the cells either die or exit
of the adult population). The infected B cells are all the cell cycle and become memory B cells. The impor-
latent, but they are resting cells, not activated blasts tant point is that activated naive or memory B cell blasts
(Miyashita et al., 1997). The periphery is a reservoir of can exit the cell cycle, without terminally differentiating,
persistent virus, since the absolute number of infected only by becoming sIg1, IgD2 memory B cells. The B cell
cells remains constant over several years (Khan et al., blasts can never dedifferentiate back into a naive state.
1996) and infectious virus can be recovered from the If EBV-infected B blasts in vivo become resting B
cells when they are cultured (Rickinson et al., 1977; cells through the same pathway as antigen-activated B
Miyashita et al., 1995). The only latent gene consistently blasts, then a number of experimentally testable predic-
found to be expressed in the periphery is LMP2a (Qu tions can be made. First, in sites of EBV replication, any
mature B cell, naive (sIgD1) or memory (sIgD2), could
be infected. However, to reach the resting state, the B³To whom correspondence should be addressed (e-mail: DThorley-
Lawson@Infonet.Tufts.Edu). blasts would have to become memory cells. Therefore,
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In this study, we show that the EBV-positive cells inTable 1. Cells Latently Infected with EBV Are Restricted to the
the peripheral blood have the characteristics of memoryIgD2 B Cell Subset in the Periphery Blood but Not Tonsils of
B cells (sIg1 sIgD2). Significant numbers of infectedPersistently Infected Healthy Donors
naive B cells (sIgD1) were not found. We propose
Number of Infected Cells/107 Total Cells
therefore that memory B cells are the site of long-term
Experimenta Total B IgD1 IgD2 EBV persistence. By comparison, both IgD1- and IgD2-
infected cells were detected in tonsillar lymphoid tissue,PBL 1 5 0b 25
a site of active viral replication and infection. We con-2 25 1c 100
3 40 1c 230 clude that the activated, proliferating state of latent in-
4 95 6 375 fection is required to allow the virus to gain access to
5 380 7 830 resting memory B cells. Access to these cells occurs not
through direct infection but through the differentiation ofTonsil 1 40 75
2 3d 70 latently infected B cells using the normal pathways by
3 70 35 which B cell blasts become memory cells.
4 15 30
5 25 200 Results
a Each experiment represents a different donor.
b No positive cells detected in 1.2 3 107 IgD1 B cells tested (95% EBV-Infected B Cells in the Peripheral Blood
confidence limit 0, 3). Are Restricted to the IgD2 B Cell Subsetc One positive cell detected in 1.2 3 107 IgD1 B cells tested (95%
Since there is no viral replication in the peripheral blood,confidence limit 0, 5).
our model predicts that infection occurs elsewhere andd Two positive cells detected in 0.6 3 107 IgD1 B cells tested (95%
that latently infected cells become resting by differenti-confidence limit 1, 7).
ating into memory cells prior to entering the peripheral
circulation. Therefore, only latently infected, memory B
at sites lacking viral replication, such as the peripheral cells should be found in the periphery. To test this pre-
blood, resting, latently infected B cells should all be in diction, we have separated B cells on the basis of sur-
face IgD expression. IgD is expressed on naive B cellsthe memory subset.
Figure 1. EBV-Infected Cells Are Restricted to the IgD2 B Cell Subset in the Peripheral Blood but Not Tonsils of Healthy Individuals
IgD2 and IgD1 B cells were fractionated from either the peripheral blood or tonsils using the MACS system as described in Experimental
Procedures. PCR products from IgD2 and IgD1 B cells from healthy donors were analyzed by Southern blot as described in Experimental
Procedures. Limiting dilution analysis was employed and absolute frequencies of EBV-infected cells in each population were determined
using Poisson statistics. The expected size of the PCR product is indicated by an arrow to the left and the absolute number of cells per
sample are given in the middle. Lanes with experimental samples are labeled with a vertical line, positive controls with a plus, negative controls
with a minus, and the molecular weight marker lane with an asterisk. The calculated frequencies are shown in Table 1. (A) FACS analysis of
IgD1 and IgD2 B cell subsets isolated from whole PBMC by sequential MACS fractionation as described in Experimental Procedures. The
populations were costained for the pan-B cell marker CD20 (FITC) and for IgD expression (PE). (B) B cells from the peripheral blood of donor
#3 (Table 1). (C) Tonsillar mononuclear cells from donor #1 (Table 1). Note that in contrast to peripheral blood, it is apparent that both the
IgD1 and IgD2 B cell subsets from tonsils harbor EBV.
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but is lost during germinal center maturation that yields
memory B cells expressing the switched isotypes (M,
G, E, and A) of hypermutated immunoglobulin genes
(Liu et al., 1996).
IgD1 B cells were positively selected from PBMC us-
ing a biotinylated aIgD monoclonal antibody and the
MACS cell fractionation system. The remaining, pre-
dominantly IgD2, B cells were then isolated using an
aCD19 antibody (a pan-B cell marker) again in conjunc-
tion with MACS beads. The absolute numbers of virus-
infected cells in each population were then assayed by
performing limiting dilution analysis. The presence or
absence of viral genomes in each sample was estab-
lished by performing a virus-specific DNA PCR reaction
(Miyashita et al., 1995). The products of the PCR reaction
were detected by Southern blotting with a virus-specific
probe. We have shown previously that this assay can
detect a single viral genome in the presence of 106 unin-
Figure 2. EBV Is Only Found in the IgD2 B Cell Subset When As-fected cells (Khan et al., 1996). Southern blots from one
sayed by RTPCR or Spontaneous Outgowth
representative donor (#3 in Table 1) are shown in Figure
(A) RT-PCR for LMP2a was performed as described in Experimental
1B. Only one signal was detected in all of the dilutions Procedures on the IgD2 and IgD1 B cell subsets, and the Southern
of IgD1 B cells tested (a total of 1.2 3 107 cells). By blot analysis of the PCR products is shown. Sample lanes for IgD1
comparison, signals were readily detected in the IgD2 and IgD2 cells are labeled and contained the PCR products from
106 of theappropriate cellpopulation. The positivecontrol is denotedpopulation. The frequencies of virus-infected cells were
as a plus and negative controls labeled with a minus. Only in thecalculated to be 230 per 107 IgD2 B cells. This experi-
IgD2 B cell subset were we able to detect the transcript for LMP2a.ment was repeated on several donors with a wide range
(B) IgD2 and IgD1 B cells from the peripheral blood were assayed,
in frequencies of infected cells, from the lowest with 5 by limiting dilution, for the frequency with which EBV transformed
per 107 B cells to the highest with 380 per 107. The results cells spontaneously arose in culture. For details see Experimental
are summarized in Table 1. It is apparent that less than Procedures. The same cells were also assayed for the frequency of
infected cells by limiting dilution and DNA PCR.1% (95% confidence limits 0.3 and 1.3) of the EBV-
infected cells reside in the naive (IgD1) B cell population.
Only in donors with thehighest numbers of EBV-infected
cells did we observe sufficient signals in the IgD1 popu- of healthy, persistently infected individuals and that es-
lation toestimate a frequency. These numbers, however, sentially all of the EBV-infected cells reside in the IgD2
were still so low compared to the IgD2 population that subset.
they could be accounted for by ,1.5% contamination
of the IgD1 population by IgD2 B cells. Therefore, we
EBV Is Restricted to the IgD2 B Cell Population
cannot tell if the infected cells in the IgD1 population
as Judged by RTPCR
represent a very small fraction, #5%, of virus-infected
LMP2a is the only viral transcript that has been consis-
cells that are truly IgD1 or are simply due to very low
tently detected in all of the published RT-PCR studies
levels of contaminating IgD2 cells.
on the peripheral blood of healthy, persistently infected
For every experiment, we monitored the purity of the
individuals (Qu and Rowe, 1992; Tierney et al., 1994;
populations before and after fractionation by staining
Chen et al., 1995; Miyashita et al., 1997). Thus, LMP2afor the specific marker selected, in this case IgD, and
expression is a second molecular marker for the pres-
the pan-B cell marker CD20. An example of such an
ence of EBV in the periphery. To confirm the results
analysis is shown in Figure 1A. The purified cells were
obtained by DNA PCR, we performed RT-PCR analysis
always ,5% contaminated with the unwanted B cell
for expression of LMP2a in IgD2 and IgD1 B cell popula-
population. In some preparations, there was significant
tions. As shown in Figure 2A, LMP2A transcripts were
contamination with non-B cells (e.g, 15% in the IgD2 B
readily detected in the IgD2 memory B cell subset only.
cells in Figure 1). However, these cells do not contain
Although it is not possible to quantitate the absolutevirus (Miyashita et al., 1995) and do not affect the inter-
numbers of cells containing the transcript, these resultspretation of the results. We also measured the frequen-
confirm, qualitatively, that viral gene expression, likecies of virus-infected cells in the unfractionated B cell
EBV DNA, is limited to the IgD2 B cell subset.population (total CD191 cells). Knowing this and the
purity of each population, we could estimate the ex-
Only the IgD2 B Cell Population Undergoespected yield of virus-infected cells after fractionation
Spontaneous Outgrowthand compare this to the observed yield. By this means,
When placed into culture, infected peripheral blood Bwe could determine that essentially all of the virus-
cells release infectious virus that will immortalize by-infected cells were recovered in the IgD2 population
stander B cellsÐso called spontaneous outgrowth (Rick-and that there had been no gross loss of cells during
inson et al., 1977). It has been reported previously thatthe isolation procedures.
the virus is released almost exclusively from IgD1 B cellsWe conclude therefore that there is not a significant
number of infected naive B cells in the peripheral blood (Lam et al., 1994). This result would appear to be in
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Table 2. IgD2 B Cells, Latently Infected with EBV in the Periphery
of Persistently Infected Healthy Donors, Are Not Limited to
a Specific Isotype
Number of Infected Cells/107 Total B Cells
Experiment M1G1E1 A1 G1 M1 G1E1A1
1 675 700
2 285 385 360
3 350a 1600
a Insufficient cells were recovered for FACS analysis. This estimate
is based on the assumption that the population is 100% pure and
therefore may be an underestimate.
cells (CD191, CD201). Although sIgD expression is the
only reliable surface marker for naive B cells in the pe-
ripheral blood, lack of sIgD does not prove that a cell
is a memory B cell. It was conceivable that the infectedFigure 3. EBV Is Evenly Distributed throughout the Memory B Cell
B cells lacked sIg expression completely and were unre-Subset
lated to memory cells. We therefore performed experi-DNA-PCR limiting dilution analysis was performed on IgD2 B cells
ments to test if the virus-infected cells expressed sur-depleted (IgD2IgA2CD191, upper panel) or enriched (IgA1, lower
panel) for the expression of IgA. The expected size of the PCR face Ig and to see if EBV-infected cells were limited to
product is indicated by an arrow to the left, and the absolute number a specific isotype. IgD2 B cellswere isolated from PBMC
of cells per sample and the fraction of samples positive for each previously depleted of IgD1 B cells. Cells expressing
cell number tested are given to the right. Lanes with experimental
various immunoglobulin isotypes were then positivelysamples are labeled with a vertical line, positive controls with a plus,
selected from the purified IgD2 B cells. We then mea-negative controls with a minus, and the molecular weight marker
sured the frequency of virus-infected cells in the se-lane with an asterisk. The calculated frequencies of infected cells
for each population are shown in Table 2, experiment #1. lected population and in the depleted population. This
experiment was performed for the IgG, IgA, and IgM
isotypes. The Southern blot result for purified IgA1 ver-contradiction to our observation that essentially all of
sus IgA2, IgD2 B cells is shown in Figure 3. The esti-the EBV-infected cells in the peripheral blood are IgD2.
mated frequencies from all of theexperiments areshownTo check this apparent contradiction, we have repeated
in Table 2. These experiments confirmed that the latentlythe spontaneous outgrowth experiments. Virus release
infected B cells express sIg. However, selective enrich-was assayed on both the IgD1 and IgD2 B cell subsets
ment for any of the switched isotypes tested did notfrom the peripheral blood. In parallel, the same cell frac-
dramatically alter the frequency of virus-infected cells. Ittions were assayed for the presence of viral DNA by
appears therefore that the virus-infected cells areevenlyPCR. Limiting dilution analysis was performed to mea-
sure the frequency of cells spontaneously releasing virus distributed throughout the memory subset but are ex-
or containing viral DNA. The results are shown in Figure cluded from naive B cells in the peripheral blood of
2B. Only in the IgD2 population did we observe signifi- healthy individuals. The restricted presence of EBV in
cant numbers of virus-infected cells by either assay. By the memory B cell subset in peripheral blood contrasts
DNA PCR, the absolute frequency of EBV-infected cells with the unrestricted infection of all B cells seen in vitro.
was 38 per 106 IgD2 and 0.6 per 106 IgD1 B cells. By
outgrowth, we estimated a frequency of 7.5 virus-releas-
EBV Actively Replicates in Tonsillar Lymphoiding cells per 106 IgD2 B cells. For the IgD1 cells, we
Tissue of Persistently Infectedobserved no outgrowth in 30 wells each containing 105
Healthy IndividualsIgD1 B cells per well (0 per 3.106). Why the estimated
We have previously shown that viral replication is notfrequency of infected cells measured by detecting the
detected in the peripheral blood (Decker et al., 1996);release of infectious virus is 5-fold lower than by DNA
therefore, B cells must be infected elsewhere prior toPCR is not clear. One possibility is that outgrowth is an
exit into the periphery. It is known that viral replicationinefficient process and is not as sensitive as PCR for
occurs in tonsillar lymphoid tissue during acute infec-detection of virally infected cells. Another possibility is
tion, i.e., infectious mononucleosis (Anagnostopoulosthat only a subset of the cells is able to release infectious
et al., 1995). Infectious virus continues to be shed intovirus. We also have no explanation for the discrepancy
the saliva throughout the lifetime of the host and thisbetween our results and those published previously.
virus probably also originates from the mucosal lymphoidHowever, in our hands the outgrowth assay is in concor-
tissue; however, this has yet to be demonstrated duedance with the DNA and RT PCR studiesÐall of the
to the very small numbers of infected cells present. Tovirus-infected cells detected in the peripheral blood re-
overcome this problem, we have employed a DNA PCR±side in the IgD2 population.
based in situ lysis gel technique (PCR Gardella gels)
that we have developed and characterized previouslyEBV Resides in and Is Distributed throughout
(Decker et al., 1996). This technique can detect the viralthe Memory B Cell Subset
DNA from a single infected cell and discriminate whetherIn the previous section, we demonstrated that latently
infected cells reside exclusively in the IgD2 subset of B it is episomal and/or linear, the forms of the viral genome
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viral DNA in tonsillar compared to PBL B cells was not
due to loading more infected tonsillar B cells onto the gel.
We conclude therefore that viral replication is actively
occurring in the tonsillar lymphoid tissue of healthy, per-
sistently infected individuals.
EBV Latently Infected Cells Are Found in Both
the IgD2 and IgD1 Subsets of Tonsillar B Cells
Active viral replication is occurring in the tonsillar
lymphoid tissue, and we know that EBV can infect all
resting B cells, including naive B cells, in vitro. We would
expect therefore that infected B cells of all types should
be present in vivo at an area of active virus production.
Specifically, and in contrast to the peripheral blood,
where no infectious virus is being produced, we would
expect both IgD2 and naive (IgD1) B cell subsets to be
infected in tonsillar lymph nodes. To test this prediction,
we separated tonsillar B cells on the basis of sIgD ex-
pression, and the frequency of virus-infected cells in
each population was again assessed by DNA PCR in
conjunction with limiting dilution analysis. The result of
one such analysis is shown in Figure 1C. EBV was de-
Figure 4. Lytic Replication of EBV Occurs in the Tonsil but Not the
tected in both the IgD1 and IgD2 B cell subset. ThePeripheral Blood
frequency of infected cells in this case was calculated
PCR-modified Gardella gel analysis was performed on different cell
to be 40 per 107 in the IgD1 B cells and 75 per 107 insubsets from tonsils. The Gardella gel is an in situ lysisgel that allows
the IgD2 B cells. Overall, we have detected EBV in thethe episomal and linear forms of the viral DNA to be fractionated. The
IgD1 B cell subset from the tonsils of four out of fiveepisomal DNA migrates more slowly than the linear DNA. After the
gel is run, the lane containing the experimental samples is excised, donors tested (Table 1). The range of frequencies was
sliced into a series of equal-size pieces, and DNA PCR for the viral slightly lower in the IgD1 subset (15±70 per 107) than
genome is performed on DNA extracted from each slice. Southern the IgD2 subset (30±200 per 107), but this difference was
blot analysis of the PCRproducts is shown. The position of episomal
not statistically significant. The exception was the tonsiland linear DNA is denoted at the top. (A) PBL B cells, a positive
in experiment 2 where the results were reminiscent ofcontrol to indicate the migration of the episomal form of the viral
peripheral blood. EBV-infected cells were present in theDNA. (B) Virions, a positive control to indicate the migration of the
linear form of the viral DNA. (C) The state of the viral genome in IgD2 B cells, but so few signals were seen in the IgD1
tonsillar lymphoid tissue. (D) Same as C but from a different donor. B cells that it was impossible to determine if this repre-
(E) IgD1 tonsillar B cells. (F) IgD2 tonsillar B cells. (G) CD192 tonsillar sented contamination with IgD2 cells or a very low fre-
B cells.
quency of infected IgD1 cells.
For two tonsils (experiments 1 and 2 in Table 1),
that are characteristic of latent or lytic infection, respec- Gardella gel and phenotypic analysis were performed
tively. When this analysis was applied to tonsillar in parallel. The tonsil from experiment 1 had linear viral
lymphoid tissue from healthy, persistently infected indi- genomes and infected IgD1 cells, whereas the tonsil
viduals (Figures 4C and 4D), linear and episomal forms in experiment 2 lacked both. Therefore, in these two
of the virus were detected; therefore, viral replication is samples there was an exact correlation between the
ongoing in this tissue. As controls for the migration rate presence of linear viral genomes and infected IgD1 cells.
of episomal and linear genomes, we used peripheral It is possible that, at the time of tonsillectomy, the tonsil
blood B (PBL-B) cells (Figure 4A) shown previously to donor for experiment 2 was not shedding virus, thereby
contain only episomes (Decker et al., 1996) and purified accounting for the lack of infected IgD1 B cells.
virions (Figure 4B, lower panel) that only contain the We conclude that the picture of viral infection in muco-
linear form of the genome. In all, we have detected linear sal lymphoid tissue represented by tonsils is different
viral DNA in five out of seven tonsils analyzed. from that found in the periphery. In the periphery, the
Linear DNA can be generated artifactually in this infection is quiescent with no viral reactivation and rein-
method due to shearing of episomal DNA during pro- fection occurring and only latently infected, IgD2 mem-
cessing. We do not believe that this is occurring, how- ory cells present. By comparison, viral replication is ac-
ever, for several reasons. First, linear viral DNA was not tively underway in tonsillar lymphoid tissue and both
present in five out of five peripheral blood samples that naive (IgD1) and IgD2 subsets of B cells are infected.
were processed in an identical manner. Second, the
linear genomes from tonsils were present in a specific
population of cells (see below). Third, linear viral DNA Both the IgD2 and IgD1 Cells Are Latently
Infected in the Tonsilwas only present when infected naive B cells were also
detected (see below). The frequencies of virus-infected We have used DNA PCR to demonstrate that EBV DNA
is associated with both the IgD1 and IgD2 B cells incells in PBL and tonsillar B cells were similar: 5±500 per
107 (Khan et al., 1996) and 20±100 per 107 (this paper) tonsils. However, lytic replication is also ongoing in the
tonsillar tissue; therefore, the PCR signals could deriveB cells, respectively. Therefore, the presence of linear
Immunity
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from intact or fragmented virion DNA bound to the out- Introduction, based on the assumption that EBV infec-
tion in vivo follows the pathways of antigen-driven acti-side of the B cells. This would explain the even distribu-
vation. First, antigen can activate naive and memory Btion of virus that we found among the tonsillar B cells.
cells in the lymphoid tissue and EBV infects naive andIt would also explain why only infected IgD2 cells were
memory B cells in the lymphoid tissue. Second, antigen-found in the one tonsil that lacked viral replication. To
activated B cells only reenter the peripheral circulationestablish if the populations were truly infected, we again
as memory B cells and EBV recirculates in resting mem-resorted to PCR Gardella gels. As shown in Figures 4E
oryB cells. The consequent prediction from these obser-and 4F, the covalently closed episomal form of the viral
vations is that EBV-infected B cells in lymphoid tissueDNA was detected in both IgD1 and IgD2 subsets. Since
differentiate in a manner that mimics the germinal centerthis assay is capable of detecting a single linear viral
reaction that generates memory cells. A plausible mech-genome, we may conclude that both subsets are latently
anism for the establishment and maintenance of persis-infected. This observation was also an important control
tence can be constructed based on these ideas. Whenbecause it rules out the possibility that the linear DNA
the virus first enters the host, during acute infection, itseen in unfractionated tonsillar lymphoid tissue in Fig-
will infect and activate any mature B cell. These latentlyures 4B and 4C was generated by artifactual shearing
infected B cell blasts disseminate and amplify the viraleffects that occurred during processing and isolation of
genome, not as free virions, but as latent episomesthe tonsillar cells. If this had occurred, then linear viral
within the proliferating cells. These B blasts can alsoDNA should also have been detected in the specifically
differentiate in lymphoid tissue, allowing the virus, in thepurified populations of IgD1 and IgD2 B cells. Linear
form of latently infected cells, to gain access to theviral DNA was associated with the CD192 population
memory subset. This continues until a strong CTL re-(Figure 4G), which includes non-B cells and terminally
sponse arises to clear the infected B blasts, which aredifferentiated plasma cells that have lost their lineage
no longer required because life-time persistence hasmarkers.
been established in the memory compartment. In fact,We conclude therefore that the DNA PCR analysis
the highly proliferative blasts would be a threat to thewas detecting intact viable genomes and that both the
host that the virus depends on for life-time persistence.IgD1 and IgD2 populations are latently infected.
Therefore, it is to the advantage of the virus that the
blasts be rapidly destroyed once persistent infection of
memory cells has been established. This conclusion isDiscussion
supported by the recent observations of Khanna et al.
(1997) that the epitopes recognized by EBV-specific CTLThe molecular biology of EBV-driven B cell proliferation
are evolutionarily conserved. This confirms that there isin vitro is beginning to be understood in detail. To under-
a selective long-term advantage to the virus, favoringstand how this process is regulated in normal infection
the destruction of infected B blasts.and then disregulated, leading to pathogenic disease,
If correct, then latently infected B cell blasts, like nor-it is necessary to study the mechanism of EBV persis-
mally activated B cells, can transition from a proliferatingtence in vivo. We still know remarkably little about how
to a resting state in vivo. Such a transition has neverthis works. In this paper, we definatively show that EBV
been shown in vitro for either infected or antigen-acti-in peripheral blood has a tropism for persistence in a
vated B blasts; however, a good deal is understoodfunctionally specific subset of B cellsÐmemory cells.
about how normal B cells achieve this in vivo (MacLen-This observation stands in contrast to the behavior of
nan, 1994; Liu et al., 1996). A simplified summary of thisthe virus in vitro where it is able to establish latency in
process is shown in Figure 5. B blasts, activated by
virtually any type of mature B cell. The quantitative na-
antigen and T helper (Th) cells via CD40, enter the folli-
ture of our DNA PCR assay allows us to conclude that
cles of germinal centers to become highly proliferative
the association with memory cells is highly specific,
centroblasts that have elevated levels of c-myc and ex-
since greater than 99% of the virus-infected B cells in press the germinal center±specific cell surface markers
the periphery were detected in the memory subset. This CD10 and CD77. After each cell division, a single resting
was confirmed by two less sensitive assays: RTPCR for cell, termed a centrocyte, is generated. Centrocytes ex-
LMP2a, the only latent transcript reproducibly shown to press the pro-apoptotic genes Fas, bax, and p53 (Marti-
be expressed in the periphery, and the biological assay nez-Valdez et al., 1996). Signals from antigen and Th
of spontaneous outgrowth. These results raise the pos- cells drive them to terminally differentiate into plasma
sibility that EBV is using the biology of long-term B cells. When antigen becomes limiting,centrocytes either
lymphocyte memory as a mechanism to sustain persis- die rapidly from apoptosis or become memory cells.
tence. There is evidence to suggest that EBV-infected B blasts
In the periphery, EBV infection is always latent, tran- can become centrocytic if the critical transcriptional reg-
scriptionally quiescent, and limited to resting, IgD2 B ulator EBNA2 is switched off (Polack et al., 1996) in
cells. In mucosal lymphoid tissue, however, the situation the presence of an activated c-myc gene. Under these
is more dynamic because viral replication is ongoing. conditions, expression of the latent proteins is lost and
This virus is released into the saliva; however, it will the cells loose surface markers characteristic of B
also infect bystander B cells. Since EBV can infect any blasts, such as CD23, and acquire germinal center±
mature B cell, it was expected that we would find the specific markers, such as CD10 (Polack et al., 1996). If
virus in both IgD1 and IgD2 tonsillar cells. correct, then infected B blasts become germinal center
cells by turning off the latent genes and proliferatingOur experiments fulfill two predictions, made in the
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Figure 5. Diagrammatic Representation of
the Steps Involved in Generating a Memory
B Cell from a Naive B Cell and the Proposed
Equivalents for EBV-Activated B Cells
The known EBV-positive lymphomas and their
proposed origin from the different stages of B
cell differentiation are also shown. The latent
gene expression indicated for each stage is
based on the known gene expression in the
respective tumors. For details see the Dis-
cussion.
under the influence of cellular genes. How could such EBV-infected cells. It is possible that these are the cells
that will return EBV to mucosal epithelium, guaranteeinga cell replicate the viral episome and continue to differ-
entiate? The solution is suggested by EBV1 Burkitt's that infectious virus is released into saliva.
Once EBV enters the memory pool, the frequency oflymphoma (BL), which is phenotypically identical to a
germinal center B cell (MacLennan et al., 1988). The only infected cells is stable for at least 6 years (Khan et al.,
1996; D. T.-L., unpublished data). Maintenance of thisviral gene expressed is EBNA1, the protein essential for
replicating the viral episome, and it is expressed via a stability may rely on the same mechanisms that sustain
long-term memory. Bcell memory isextremely long livedunique promoter, Qp (Nonkwelo et al., 1996; Schaefer
et al., 1995). Qp may be regulated in such a way that if (reviewed in Tough and Sprent, 1995), with recall being
detected decades after primary exposure to an antigen.an infected B blast makes the transition to a centroblast
by down-regulating the latent genes and expressing Memory B cells only divide once every several months
(Schittek and Rajewsky, 1990) but seem to require fre-c-myc, EBNA1 expression will automatically be acti-
vated through Qp. If true, then BL is a tumor of an EBV- quent stimulation through a functional BCR for survival
(Gray and Skarvall, 1988; Lam et al., 1997). The originsinfected centroblast and the Qp/EBNA1 only form of
transcription is the latency state characteristic of that of this signal in normal B cells are unclear, since it is
highly unlikely that antigen can persist for decades. Wecell.
If these EBV-infected centroblasts produce a centro- have speculated previously that resting memory B cells
latently infected by EBV may be maintained by signalingcyte after each division, how are the centrocytes res-
cued from apoptosis? A solution is suggested by studies through LMP2a (Miyashita et al., 1997). This is the only
latent gene consistently found to be expressed in theseon another EBV1 tumor, Hodgkin's lymphoma (HL). It
has recently been shown that HL is a tumor of the cells and has an intact ITAM (Beaufils et al., 1993), the
signaling motif found in the BCR. More recently, it hascentrocytic or postcentrocytic stage of Bcell differentia-
tion (Kuppers et al., 1994). HL cells express LMP1 and been shown that LMP2a can indeed provide a rescue
signal that replaces the BCR for development of B cellsLMP2 (Deacon et al., 1993) by an EBNA2-independent
mechanism that is not currently understood. LMP-1 is in the bone marrow of LMP2a transgenic mice (Caldwell
et al., 1998). At present, we cannot measure the lifetimebelieved to signal in a manner that mimics CD40 and
related members of the TNF receptor family which are of latently infected cells in the periphery. Therefore, we
cannot distinguish whether individual cells are ex-critical in rescuing centrocytes. LMP2 contains thesame
signaling motif as the BCR complex (see below) and tremely long lived or are being continuously replaced
through sporadic proliferation and/or new infection. Thecan provide a BCR-related rescue signal (Caldwell et
al., 1998). Therefore, in principle LMP1 and 2 could pro- only study of latently infected cells in individuals where
viral replication was blocked by acyclovir (Yao et al.,vide the rescue signals that allow the centrocyte to sur-
vive and differentiate into a resting memory B cell that 1989) was not carried out long enough to effectively test
if infection was necessary for long-term persistence.expresses only LMP2a.
It is unclear how the relative numbers of normal mem- Although differentiation is an attractive model to ex-
plain the selective presence of EBV in memory B cellsory B cells expressing the various isotypes are regu-
lated. It is interesting therefore that EBV, in the periph- in the periphery, there are other possible explanations.
Specifically, it could simply be that the infected IgD1ery, is distributed throughout the memory subset while
being excluded from all naive cells. EBV is believed cells generated in the lymphoid tissue are too short lived
to enter the periphery or that they fail to differentiateto enter and be released through mucosal epithelium;
therefore, it was conceivable that the virus was limited and are lysed by CTL. It should be possible to distinguish
these various possibilities by careful analysis of Bto the IgA1 subset, which preferentially homes to this
tissue. Although this was not the case, we did find IgA1, lymphoid subsets and by studies on immunosuppressed
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times. The MACS column (AS type) was prepared by rinsing withindividuals. For example, we found that both the IgD1
10 ml of PBSA and then inserted into a varioMACS magnet. Theand IgD2,CD191 populations in tonsils are latently in-
flow rate of the column was adjusted by attaching a 25G needle tofected. It will be important to know whether the IgD2
the base of the stopcock. Cells were then loaded onto the column,
cells include all B cells from centroblast through to mem- and the negative fraction was collected. The cells were washed
ory cells or are restricted only to memory cells. If the through by applying 3 ml of PBSA to the column while still attached
to the magnet. The retained population was then washed by remov-latter is true, it would suggest that virus-infected cells
ing the column from the magnet and injecting 2 ml of PBSA fromdo not differentiate and that the infected IgD1 cells are
the bottom of the column using the side syringe supplied. The 25Gabsent from the circulation because they are short lived.
needle was then replaced with a 23G needle, the column was rein-If virus-infected cells are present throughout the gamut
serted into the magnet, and cells were allowed to flow through.
of differentiating B cell types, it will be important to know These cells were collected as the wash fraction and discarded. The
if latent gene expression in these populations follows column was again rinsed with 3 ml of PBSA as before to remove
any remaining nonspecifically bound cells. The column was thenthat predicted from the model in Figure 5.
removed from the magnet, the 23G needle removed, and the columnMany other questions remain to be addressed about
washed with 10 ml of PBSA to elute the retained cells.For separationthe nature of the infection that is ongoing in the lymphoid
of other cell populations, the same general protocol was performedtissues. It will be interesting to see if viral replication
using the following concentrations of biotinylated antibody: aCD19
is restricted to mucosal lymphoid tissue since EBV is (our lab), 0.018 mg for PBMC, 0.072 mg for tonsil; aIgA (Southern
presumably only released onto mucosal surfaces. This Biotec), 0.25 mg for PBMC; aIgG and aIgM (Southern Biotec), 0.025
mg for PBMC. For analysis of memory B cells expressing differentincludes further characterization of the cells that repli-
isotypes, IgD1 B cells were first depleted from whole PBMC ascate the virus. In tonsils from donors with acute infec-
described above, and the remaining IgD2 B cells were isolated bytion, these cells are terminally differentiated B cells that
positive selection using the Multi-Sort kit (Miltenyi). Flow cytometrichave lost their lineage markers (Anagnostopoulos et al.,
analysis was used to determine the purity of the cell populations
1995). This is consistent with our observation that the before and after MACS separation. The positively selected popula-
cells replicating the virus in the tonsils of persistently tions were always greater than 85% pure and usually greater than
95% pure.infected individuals are CD192. If true, this would imply
that EBV-infected cells are capable of differentiating
FACS Analysis and Antibodiesinto either memory or plasma cells and would implicate
All fractionated populations wereanalyzed using a BectonDickinsonvirtually every aspect of mature B cell biology in the
FACScan with Lysis II software. After separations, all fractions were
mechanism of EBV persistence. stained with an antibody to the appropriate isotype conjugated to
In conclusion, EBV persistence in vivo provides a PE (Southern Biotec) as well as aCD20-FITC (DAKO). FACS analysis
unique opportunity to study and understand how poten- allowed for determination of both the recovery and purity of the
isolated populations. As negative controls, MOPC21 (IgG1 isotypetially pathogenic viruses have evolved complex strate-
control, Sigma), 1a2 (IgG2a isotype control, this laboratory), andgies to integrate their biology with that of the host cells
MOPC121 (IgG2b isotype control, Sigma) were used.they occupy.
PCR and PCR Product Analysis
Experimental Procedures Isolated populations were aliquoted at the desired number into a
96-well V-bottom microtiter plate (Immulon). The plate was centri-
Primary Cells and Cell Lines fuged at 1500 rpm for 15 min at 48C and the supernatant aspirated.
Namalwa (ATCC) is an EBV1 BL line. It contains one or two copies 10 ml of a lysis solution containing 0.45% Tween-20, 0.45% NP-40,
of the EBV genome and was used as a positive control for all PCR 2 mM MgCl2, 50 mM KCl, 10 mM Tris (pH 8.3), and 0.5 mg/ml Protein-
reactions. BJAB is an EBV2 B cell lymphoma that was used as a ase K was added to each well and the plate incubated for at least
negative control for all experiments and as carrier cells when the 2 hr at 558C. After incubation, the plate was centrifuged quickly to
PBMC number tested was less than 1 3 104 cells. IB4 is an EBV1 remove condensation from the lid of the plate. PCR was performed
lymphoblastoid cell line used as a positive control for LMP2a in a final volume of 50 ml per reaction. 5 ml of cell lysate was added
RT-PCR. to each PCR reaction. The PCR and Southern blotting conditions
Heparinized peripheral blood (240 ml) obtained from healthy do- used were exactly as previously described (Miyashita et al., 1995).
nors was layered onto Ficoll-Hypaque (Pharmacia) and centrifuged To determine the absolute number of infected cells in each popu-
at 2000 rpm for 30 min at 258C. Buffy coats were removed and lation, a limiting dilution analysis was performed as described pre-
washed two times with PBSA (13 PBS/0.5% BSA) at 1200 rpm for viously (Miyashita et al., 1995; Khan et al., 1996). The DNA PCR can
15 min. PBMCs were then resuspended at a concentration of 2 3 detect the presence of a single viral genome in as many as 106
107 cells/ml in the same buffer. uninfected cells. Poisson statistics were used to calculate the fre-
Tonsils were obtained from patients undergoing routine tonsillec- quency of EBV-infected cells. To exclude the possibility of external
tomies, primarily for obstructed breathing disorders, at the New contamination of the DNA PCR, we included eight negative DNA
England Medical Center. Tonsils were minced in PBSA and the samples per analysis. Furthermore, the lack of contamination could
resulting suspension was passed through silkscreen to remove any be confirmed since the PCR signals always fractionate consistently,
connective tissue. The cell suspension was diluted to 1 3 108 cells/ for example into the IgD2 subset of PBL-B cells, and the signals
ml, layered onto Ficoll-Hypaque, and processed as above. titrated out, i.e., they were weaker and less frequent with fewer cells.
LMP2a RT-PCRMagnetic Bead Separations
PBMCs and tonsillar mononuclear cells were resuspended to 2 3 RNA was purified from up to 5 3 106 cells with Trizol (GIBCO) as
described by the manufacturer. RNA pellets were resuspended in107 cells/ml in PBSA as 1 ml aliquots. Biotinylated aIgD antibody
(Southern Biotec cat #2030±08) was added to each tube (0.015 mg 10 ml of RNAse free H2O and subjected to cDNA synthesis by adding
2 ml of random hexamers (50 ng/ml) and incubating at 708C for 10for PBMCs and 0.060 mg for tonsillar cells) and incubated on a
rotator at 48C for 30 min. All tubeswere washed two times with PBSA min. The tube was then quickly cooled on ice and quickly spun. 1
ml of 10 mM dNTPs, 2 ml of 100 mM DTT, 2 ml of 25 mM MgCl2, andand resuspended to 180 ml in the same buffer. 20 ml of streptavidin-
coated microbeads (Miltenyi) was added to each and incubated for 2 ml of 103 RT Buffer (500 mM KCl and 200 mM Tris [pH 8.4])
were added to the tube and incubated at 258C for 5 min. 50 U of15 min at 48C. Cells were again washed and resuspended in 500 ml
for separation using MACS columns (Miltenyi) and kept at 48C at all Superscript reverse transcriptase (GIBCO-BRL) was added and the
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tube was further incubated at 258C for 10 min followed by incubation Decker, L.L., Klaman, L.D., and Thorley-Lawson, D.A. (1996). Detec-
tion of the latent form of Epstein-Barr virus DNA in the peripheralat 428C for 50 min. Following cDNA synthesis, reactions were incu-
blood of healthy individuals. J. Virol. 70, 3286±3289.bated at 708C for 15 min to inactivate the reverse transcriptase.
cDNA was ethanol-precipitated, washed, and resuspended in 10 ml Gray, D., and Skarvall, H. (1988). B-cell memory is short-lived in the
of HPLC H2O. LMP2a PCR was subsequently performed on the absence of antigen. Nature 336, 70±73.
entire cDNA sample using amplimers and reaction conditions as Hurley, E.A., and Thorley-Lawson, D.A. (1988). B cell activation and
described previously. In brief, the PCR contained 10 mM Tris (pH the establishment of Epstein-Barr virus latency. J. Exp. Med. 168,
8.3), 2.0 mM MgCl2, 50 mM KCl, 0.2 mM dNTP, and 10 pM of each 2059±2075.
amplimer. The ªhot startº method was used, and the reaction tem-
Khan, G., Miyashita, E.M., Yang, B., Babcock, G.J., and Thorley-peratures were 958C for 15 sec, 498C for 15 sec, and 728C for 30
Lawson, D.A. (1996). Is EBV persistence in vivo a model for B cellsec, with a total of 40 cycles followed by a 5 min 728C extension
homeostasis? Immunity 5, 173±179.step. PCR products were resolved on a 2% Nuseive, 1% agarose
Khanna, R., Slade, R.W., Poulsen, L., Moss, D.J., Burrows, S.R.,gel and transferred to Nytran for Southern blotting as described by
Nicholls, J., and Burrows, J.M. (1997). Evolutionary dynamics ofthe manufacturer. Blots were probed using PCR product for LMP2a
genetic variation in Epstein-Barr virus isolates of diverse geographi-derived from the IB4 cell line. This product was random primed
cal origins: evidence for immune pressure-independent genetic drift.labeled and products were detected as previously described (Miya-
J. Virol. 71, 8340±8346.shita et al., 1997).
Kieff, E. (1996). Epstein-Barr virus and its replication. In Virology,
B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (New York: RavenGardella Gel Analysis
Press), pp. 2343±2396.PCR-modified Gardella gel analysis was performed as previously
Kuppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fi-described (Decker et al., 1996). In brief, intact cells were lysed in
scher, R., and Hansmann, M.L. (1994). Hodgkin disease: Hodgkinsitu and linear genomes were resolved from circular genomes on a
and Reed-Sternberg cells picked from histological sections show0.75% agarose gel. Each lane is sliced into many sections from
clonal immunoglobulin gene rearrangements and appear to be de-which DNA is subsequently purified for EBV-specific DNA PCR.
rived from B cells at various stages of development. Proc. Natl.Linear DNA migrates faster than episomal DNA, and the exact migra-
Acad. Sci. USA 91, 10962±10966.tion point can be defined using virions as a source of linear DNA
Lam, K.M., Whittle, H., Grzywacz, M., and Crawford, D.H. (1994).and PBL-B cells as a source of episomal DNA.
Epstein-Barr virus-carrying B cells are large, surface IgM, IgD2bear-
ing cells in normal individuals and acute malaria patients. Immunol-Spontaneous Outgrowth Assay
ogy 82, 383±388.Peripheral blood cell populations were tested for spontaneous out-
Lam, K.P., Kuhn, R., and Rajewsky, K. (1997). In vivo ablation ofgrowth as described (Lam et al., 1994). 1 3 105 cells were aliquoted
surface immunoglobulin on mature B cells by inducible gene tar-into wells of a microtiter plate containing 9 3 105 cord blood cells.
geting results in rapid cell death. Cell 90, 1073±1083.Cells were grown at 378C with 5% CO2 and fed with RPMI-1640/10%
FCS twice weekly. At 1 month, all wells werescored for outgrowth by Liu, Y.J., Arpin, C., de Bouteiller, O., Guret, C., Banchereau, J.,
microscopic examination as well as performing the EBV-specific Martinez-Valdez, H., and Lebecque, S. (1996). Sequential triggering
DNA PCR described above on an aliquot taken from each well to of apoptosis, somatic mutation and isotype switch during germinal
confirm the presence of the virus. center development. Semin. Immunol. 8, 169±177.
MacLennan, I.C. (1994). Germinal centers. Annu. Rev. Immunol. 12,
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